Early Postoperative Cardiac Complication Flowing Heart Transplantation

Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, inci-dence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):1-12.

https://doi.org/10.1186/s12889-021-10429-0

PMid:33632204 PMCid:PMC7905904

Yurievich AA, Viktorovna SO, Sergeevich R, Ivanovich KD, Vladimirovich RO, Mikhay-lovich NA et al. Clinical Management of Cardiovascular Care on the Basis of Big Da-ta: Electronic Medical Records. J. Med. Chem. Sci. 2021;4(4):395-403.

Khalil Arjmandi R, Asharein MR. Case Study of Femoral and Radial Angiography in Cardiovascular Patients. Chem. Methodol.5(1):1-10.

Şahin B, İlgün G. Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries. Health Soc Care Community. 2022;30(1):73-80.

https://doi.org/10.1111/hsc.13156

PMid:32909378

Bahaoddini A, Alsadat Miryousefiata F. Therapeutic Effects of Hydro-alcoholic Ex-tract of Papaver Rhoeas on Cardiovascular side effect of MIA Induced Osteoarthritis in male Rat. Prog. chem. biochem. res. 2020;3(4):340-9.

Hudiyawati D, Ainunnisa K, Riskamala G. Self-care and its related factors among pa-tients with congestive heart failure in Surakarta, Indonesia. J. Med. Chem. Sci. 2021;4(4):364-73.

Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716-99.

https://doi.org/10.1093/eurheartj/ehab892

PMid:35016208

Safapoor S, Yazdani H, Shahabi P. A Review on Synthesis and Applications of Statin Family Drugs as a New Generations of Anti-Blood Medicines. J. chem. rev.2(1):1-27.

https://doi.org/10.33945/SAMI/JCR.2020.1.1

Mannoh I, Hussien M, Commodore-Mensah Y, Michos ED. Impact of social determi-nants of health on cardiovascular disease prevention. Curr Opin Cardiol. 2021;36(5):572-9.

https://doi.org/10.1097/HCO.0000000000000893

PMid:34397464

Ndejjo R, Musinguzi G, Nuwaha F, Bastiaens H, Wanyenze RK. Understanding fac-tors influencing uptake of healthy lifestyle practices among adults following a com-munity cardiovascular disease prevention programme in Mukono and Buikwe dis-tricts in Uganda: A qualitative study. PLoS One. 2022;17(2):e0263867.

https://doi.org/10.1371/journal.pone.0263867

PMid:35176069 PMCid:PMC8853581

Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL et al. Ten things to know about ten cardiovascular disease risk factors. AJPC. 2021;5:100149.

https://doi.org/10.1016/j.ajpc.2021.100149

PMid:34327491 PMCid:PMC8315386

Pederiva C, Capra ME, Biasucci G, Banderali G, Fabrizi E, Gazzotti M et al. Lipopro-tein (a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group. Atherosclerosis. 2022;349:233-9.

https://doi.org/10.1016/j.atherosclerosis.2022.04.021

PMid:35562202

Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56.

https://doi.org/10.1002/ejhf.1858

PMid:32483830 PMCid:PMC7540043

Braunwald E. The war against heart failure: the Lancet lecture. The Lancet. 2015;385(9970):812-24.

https://doi.org/10.1016/S0140-6736(14)61889-4

PMid:25467564

Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeu-tic approaches. Heart Fail. 2020;8(7):523-36.

https://doi.org/10.1016/j.jchf.2020.01.014

PMid:32535126

Yancy CW, Januzzi JL, Allen LA, Butler J, Davis LL, Fonarow GC et al. 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018;71(2):201-30.

https://doi.org/10.1016/j.jacc.2017.11.025

PMid:29277252

Breathett K, Yee E, Pool N, Hebdon M, Crist JD, Yee RH et al. Association of gender and race with allocation of advanced heart failure therapies. JAMA network open. 2020;3(7):e2011044-e.

https://doi.org/10.1001/jamanetworkopen.2020.11044

PMid:32692370 PMCid:PMC7412827

Losman JG, Barnard CN, Bartley TD. Hemodynamic evaluation of left ventricular by-pass with a homologous cardiac graft. J. Thorac. Cardiovasc. 1977;74(5):695-708.

https://doi.org/10.1016/S0022-5223(19)41205-1

PMid:410998

Mangini S, Alves BR, Silvestre OM, Pires PV, Pires LJT, Curiati MNC et al. Heart transplantation. Einstein (Sao Paulo). 2015;13:310-8.

https://doi.org/10.1590/S1679-45082015RW3154

PMid:26154552 PMCid:PMC4943829

Colombo D, Ammirati E. Cyclosporine in transplantation-a history of converging timelines. J Biol Regul Homeost Agents. 2011;25(4):493-504.

Smith KB, Potters TO, Zenarosa GL. Pretransplant survival of patients with end-stage heart failure under competing risks. PLoS One. 2022;17(8):e0273100.

https://doi.org/10.1371/journal.pone.0273100

PMid:35960742 PMCid:PMC9374238

Hernandez GA, Lemor A, Clark D, Blumer V, Burstein D, Byrne R et al. Heart trans-plantation and in-hospital outcomes in adult congenital heart disease patients with Fontan: A decade nationwide analysis from 2004 to 2014. J Card Surg. 2020;35(3):603-8.

https://doi.org/10.1111/jocs.14430

PMid:31971277

Sobrino-Márquez J, Grande-Trillo A, Cantero-Pérez E, Rangel-Sousa D, Lage-Galle E, Adsuar-Gómez A, editors. Prognostic value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure. Transplant. Proc.; 2018: Elsevier.

https://doi.org/10.1016/j.transproceed.2017.11.060

PMid:29579878

Aiad N, Elnabawai YA, Li B, Narula N, Gidea C, Katz SD et al. Missed opportunities in identifying cardiomyopathy aetiology prior to advanced heart failure therapy. Heart Lung Circ. 2022;31(6):815-21.

https://doi.org/10.1016/j.hlc.2021.12.014

PMid:35165053

Urschel S, Ballweg JA, Cantor RS, Koehl DA, Reinhardt Z, Zuckerman WA et al. Clini-cal outcomes of children receiving ABO-incompatible versus ABO-compatible heart transplantation: a multicentre cohort study. Lancet Child Adolesc. 2021;5(5):341-9.

https://doi.org/10.1016/S2352-4642(21)00023-7

PMid:33743201

Kim I-C, Youn J-C, Kobashigawa JA. The past, present and future of heart transplan-tation. Korean Circ J. 2018;48(7):565-90.

https://doi.org/10.4070/kcj.2018.0189

PMid:29968430 PMCid:PMC6031715

Rahm AK, Helmschrott M, Darche FF, Thomas D, Bruckner T, Ehlermann P et al. Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survival. ESC Heart Failure. 2021;8(5):3737-47.

https://doi.org/10.1002/ehf2.13494

PMid:34213089 PMCid:PMC8497214

Joglar JA, Wan EY, Chung MK, Gutierrez A, Slaughter MS, Bateson BP et al. Man-agement of arrhythmias after heart transplant: current state and considerations for future research. Circ Arrhythm Electrophysiol. 2021;14(3):e007954.

https://doi.org/10.1161/CIRCEP.120.007954

PMid:33685207

Rivinius R, Helmschrott M, Rahm A-K, Darche FF, Thomas D, Bruckner T et al. Risk factors and survival of patients with permanent pacemaker implantation after heart transplantation. J Thorac Dis. 2019;11(12):5440.

https://doi.org/10.21037/jtd.2019.11.45

PMid:32030263 PMCid:PMC6988084

Magnano AR, Garan H. Catheter ablation of supraventricular tachycardia in the transplanted heart: a case series and literature review. Pacing Clin Electrophysiol. 2003;26(9):1878-86.

https://doi.org/10.1046/j.1460-9592.2003.00284.x

PMid:12930504

Drogalis-Kim DE, Gallotti RG, Blais BA, Perens G, Moore JP. Clinical and electrophys-iological properties of atrial tachycardia after pediatric heart transplantation. Pacing Clin Electrophysiol. 2018;41(9):1093-100.

https://doi.org/10.1111/pace.13415

PMid:29893416

Nof E, Stevenson WG, Epstein LM, Tedrow UB, Koplan BA. Catheter ablation of atrial arrhythmias after cardiac transplantation: Findings at EP study utility of 3-D map-ping and outcomes. J Cardiovasc Electrophysiol. 2013;24(5):498-502.

https://doi.org/10.1111/jce.12078

PMid:23387552

Cantillon DJ. Atrial tachyarrhythmias after cardiac transplantation. Card Electrophys-iol Clin. 2012;4(3):455-60.

https://doi.org/10.1016/j.ccep.2012.05.006

PMid:26939965

Elsik M, Teh A, Ling L-H, Virdee M, Parameshwar J, Fynn SP et al. Supraventricular arrhythmias late after orthotopic cardiac transplantation: electrocardiographic and electrophysiological characterization and radiofrequency ablation. Europace. 2012;14(10):1498-505.

https://doi.org/10.1093/europace/eus092

PMid:22523376

Noworolski R, Przybylowski P, Majewski J, Sadowski J, Lelakowski J, editors. Early and late indications for implantation of cardiac pacemakers in patients after heart transplantation: a single-center experience. Transplant. Proc.; 2011: Elsevier.

https://doi.org/10.1016/j.transproceed.2011.08.039

PMid:21996229

Rubin GA, Wan EY. Leadless Pacemakers after Cardiac Transplantation. ASAIO J. 2020;66(3):e57.

https://doi.org/10.1097/MAT.0000000000001114

PMid:31996537

Anselmino M, Matta M, Saglietto A, Gallo C, Gaita F, Marchetto G et al. Long-term atrial arrhythmias incidence after heart transplantation. Int J Cardiol. 2020;311:58-63.

https://doi.org/10.1016/j.ijcard.2020.04.019

PMid:32331908

Taylor ME, McDiarmid AK, Matthews IG, Kakarla J, McComb JM, Parry G et al. A ret-rospective evaluation of catheter ablation in atrial flutter post cardiac transplanta-tion. Clin Transplant. 2021;35(10):e14429.

https://doi.org/10.1111/ctr.14429

Rodriguez-Entem F, Exposito V, Gonzalez-Enriquez S, Garcia-Camarero T, Olalla J, editors. Atrial flutter after heart transplantation: mechanism and catheter ablation. Transplant. Proc.; 2010: Elsevier.

https://doi.org/10.1016/j.transproceed.2010.04.067

PMid:20832572

Sohns C, Marrouche NF, Costard-Jäckle A, Sossalla S, Bergau L, Schramm R et al. Catheter ablation for atrial fibrillation in patients with end-stage heart failure and eligibility for heart transplantation. ESC Heart Failure. 2021;8(2):1666-74.

https://doi.org/10.1002/ehf2.13150

PMid:33314690 PMCid:PMC8006697

Ermis C, Zadeii G, Zhu AX, Fabian W, Collins J, Lurie KG et al. Improved Survival of Cardiac Transplantation Candidates with Implantable Cardioverter Defibrillator Therapy: Role of Beta-Blocker or Amiodarone Treatment. J Cardiovasc Electrophys-iol. 2003;14(6):578-83.

https://doi.org/10.1046/j.1540-8167.2003.02590.x

PMid:12875416

Sakamoto S-I, Ishii Y, Otsuka T, Mitsuno M, Shimokawa T, Isomura T et al. Multicen-ter randomized study evaluating the outcome of ganglionated plexi ablation in maze procedure. Gen Thorac Cardiovasc Surg. 2022:1-8.

https://doi.org/10.1007/s11748-022-01820-8

PMid:35476249

Suwalski G, Suwalski P. Successful surgical ablation of atrial fibrillation does not dis-turb long-term sinus rhythm variability. Interact Cardiovasc Thorac Surg. 2018;27(4):520-4.

https://doi.org/10.1093/icvts/ivy117

PMid:29672694

Cohn WE, Gregoric ID, Radovancevic B, Wolf RK, Frazier O. Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann. Cardiothorac. Surg. 2008;85(1):56-8.

https://doi.org/10.1016/j.athoracsur.2007.07.037

PMid:18154778

Barnea Y, Lerner A, Aizic A, Navon-Venezia S, Rachi E, Dunne MW et al. Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis. J Antimicrob Chemother. 2016;71(2):460-3.

https://doi.org/10.1093/jac/dkv357

PMid:26518048

Singh K, Anderson E, Harper JG, editors. Overview and management of sternal wound infection. Seminars in plastic surgery; 2011: © Thieme Medical Publishers.

https://doi.org/10.1055/s-0031-1275168

PMid:22294940 PMCid:PMC3140234

Fleck T, Moidl R, Grimm M, Wolner E, Zuckermann A. Vacuum assisted closure ther-apy for the treatment of sternal wound infections after heart transplantation: pre-liminary results. Zentralbl Chir. 2007;132(2):138-41.

https://doi.org/10.1055/s-2007-960650

PMid:17516320

Carrier M, Perrault LP, Pellerin M, Marchand R, Auger P, Pelletier GB et al. Sternal wound infection after heart transplantation: incidence and results with aggressive surgical treatment. Ann. Cardiothorac. Surg. 2001;72(3):719-23.

https://doi.org/10.1016/S0003-4975(01)02824-7

PMid:11565647

Kohli M, Yuan L, Escobar M, David T, Gillis G, Garcia M et al. A risk index for sternal surgical wound infection after cardiovascular surgery. Infect Control Hosp Epidemiol. 2003;24(1):17-25.

https://doi.org/10.1086/502110

PMid:12558231

Akar AR, Sarıcaoğlu MC, Çakıcı M, Inan MB. Candida mediastinitis: alarming clinical entity from a case-matched comparative study. Oxford University Press; 2022. p. 531-2.

https://doi.org/10.1093/ejcts/ezac001

PMid:35051266

Hamaguchi R, Shekar PS, Johnson JA, Orgill DP. Current management of sternal wounds. Plast Reconstr Surg. 2021;148(6):1012e-25e.

https://doi.org/10.1097/PRS.0000000000008510

PMid:34847131

Filsoufi F, Rahmanian PB, Castillo JG, Pinney S, Broumand SR, Adams DH. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. The J. Heart Lung Transplant. 2007;26(11):1084-90.

https://doi.org/10.1016/j.healun.2007.07.036

PMid:18022072

Wallen TJ, Habertheuer A, Gottret JP, Kramer M, Abbas Z, Siki M et al. Sternal wound complications in patients undergoing orthotopic heart transplantation. J Card Surg. 2019;34(4):186-9.

https://doi.org/10.1111/jocs.14003

PMid:30803021

O'Keeffe N, Concannon E, Stanley A, Dockery P, McInerney N, Kelly JL. Cadaveric evaluation of sternal reconstruction using the pectoralis muscle flap. ANZ J Surg. 2019;89(7-8):945-9.

https://doi.org/10.1111/ans.15268

PMid:31155817

Fleck T, Moidl R, Grimm M, Wolner E, Zuckermann A. VAC-Therapie zur Behandlung von sternalen Wundinfektionen nach Herztransplantation: Erste Ergebnisse. Zen-tralbl Chir. 2007;132(02):138-41.

https://doi.org/10.1055/s-2007-960650

PMid:17516320

Eifert S, Kronschnabl S, Kaczmarek I, Reichart B, Vicol C. Omental flap for recurrent deep sternal wound infection and mediastinitis after cardiac surgery. Thorac Cardio-vasc Surg. 2007;55(06):371-4.

https://doi.org/10.1055/s-2007-965305

PMid:17721846

Boulemden A, Speggiorin S, Pelella G, Lotto AA. Use of an extracellular matrix patch for sternal wound dehiscence after cardiac surgery in a neonate. Tex Heart Inst J. 2018;45(3):176-8.

https://doi.org/10.14503/THIJ-17-6239

PMid:30072858 PMCid:PMC6059502

Yu J, Wu R, Xiong B, Huang Z, Li H, editors. Metagenomic Next-Generation Sequenc-ing in the Diagnosis of Deep Sternal Wound Infection After Cardiac Transplantation: A Case Report and Literature Review. Heart Surg Forum; 2021.

https://doi.org/10.1532/hsf.4169

PMid:34962473

Lin C-H, Lin C-H, Tsai F-C, Lin P-J. Unilateral Pedicled Pectoralis Major Harvested by Endoscopic-Assisted Method Achieves Adequate Management of Sternal Infection and Mediastinitis. J Reconstr Microsurg. 2019;35(09):705-12.

https://doi.org/10.1055/s-0039-1695089

PMid:31362322

Cove ME, Spelman DW, MacLaren G. Infectious complications of cardiac surgery: a clinical review. J Cardiothorac Vasc Anesth. 2012;26(6):1094-100.

https://doi.org/10.1053/j.jvca.2012.04.021

PMid:22765993 PMCid:PMC3613597

Gómez-López R, Barge-Caballero E, Fernández-Ugidos P, Paniagua-Martin MJ, Barge-Caballero G, Couto-Mallón D et al. In-Hospital Post-Operative Infection after Heart Transplantation: Epidemiology, Clinical Management, and Outcome. Surg In-fect (Larchmt). 2020;21(2):179-91.

https://doi.org/10.1089/sur.2019.073

PMid:31584336

Shultes KC, Shuster JE, Micek S, Vader JM, Balsara K, Itoh A et al. Outcomes and predictors of early infection after heart transplantation. Surg Infect (Larchmt). 2018;19(5):516-22.

https://doi.org/10.1089/sur.2017.295

PMid:29775554

Bhatt PJ, Ali M, Rana M, Patel G, Sullivan T, Murphy J et al. Infections due to multi-drug-resistant organisms following heart transplantation: Epidemiology, microbiolo-gy, and outcomes. Transpl Infect Dis. 2020;22(1):e13215.

https://doi.org/10.1111/tid.13215

PMid:31765045

Rostad CA, Wehrheim K, Kirklin JK, Naftel D, Pruitt E, Hoffman TM et al. Bacterial in-fections after pediatric heart transplantation: epidemiology, risk factors and out-comes. J. Heart Lung Transplant. 2017;36(9):996-1003.

https://doi.org/10.1016/j.healun.2017.05.009

PMid:28583371

Duero Posada JG, Moayedi Y, Alhussein M, Bunce PE, Yau TM, Ross HJ. Early pneu-mopericardium after heart transplantation. Transpl Infect Dis. 2018;20(1):e12800.

https://doi.org/10.1111/tid.12800

PMid:29105898

Angleitner P, Arnoldner MA, Zuckermann AO, Aliabadi-Zuckermann AZ. Severe gas-troparesis after orthotopic heart transplantation. Eur J Cardiothorac Surg. 2021;59(3):717-9.

https://doi.org/10.1093/ejcts/ezaa309

PMid:32929471

Roest S, Brugts JJ, van Kampen JJ, Jan H, Constantinescu AA, Caliskan K et al. COVID-19-related myocarditis post-heart transplantation. Int J Infect Dis. 2021;107:34-6.

https://doi.org/10.1016/j.ijid.2021.04.013

PMid:33862215 PMCid:PMC8056480

Boutolleau D, Coutance G, Désiré E, Bouglé A, Bréchot N, Leprince P et al. Associa-tion between cytomegalovirus infection and allograft rejection in a large contempo-rary cohort of heart transplant recipients. Transpl Infect Dis. 2021;23(4):e13569.

https://doi.org/10.1111/tid.13569

PMid:33452851

Yetmar ZA, Lahr B, Brumble L, Gea Banacloche J, Steidley DE, Kushwaha S et al. Epi-demiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients. Transpl Infect Dis. 2021;23(5):e13714.

https://doi.org/10.1111/tid.13714

PMCid:PMC8702471

de Santis A, Gilberto GM, Mangini S, Megale AB, Gaiotto FA, Terra RM et al. A med-ical epopee: recurrent fungal endocarditis, heart transplantation and chylopericardi-um. BMC Cardiovasc Disord. 2020;20(1):1-6.

https://doi.org/10.1186/s12872-020-01755-z

PMid:33129270 PMCid:PMC7603709

Multani A, Moayedi Y, Puing A, Henricksen E, Garvert DW, Gomez CA et al. Recent trends of infectious complications following heart transplantation. Transplantation. 2020;104(10):e284-e94.

https://doi.org/10.1097/TP.0000000000003307

PMid:32413012

Foroutan F, Malik A, Nelson LMS, Steve C-PF, Guyatt G, Gustafsson F et al. Associa-tion between routine measures of graft function and mortality in heart transplant recipients. Heart. 2022;108(4):307-11.

https://doi.org/10.1136/heartjnl-2020-318721

PMid:33707225

Lozano-Edo S, Sánchez-Lázaro I, Portolés M, Roselló-Lletí E, Tarazón E, Arnau-Vives MA et al. Plasma levels of SERCA2a as a noninvasive biomarker of primary graft dys-function after heart transplantation. Transplantation. 2022;106(4):887-93.

https://doi.org/10.1097/TP.0000000000003798

PMid:33901112

Jahania MS, Mullett TW, Sanchez JA, Narayan P, Lasley RD, Mentzer Jr RM. Acute al-lograft failure in thoracic organ transplantation. J Card Surg. 2000;15(2):122-8.

Fujita T, Toda K, Yanase M, Seguchi O, Murata Y, Ishibashi-Ueda H et al. Risk factors for post-transplant low output syndrome. Eur J Cardiothorac Surg. 2012;42(3):551-6.

https://doi.org/10.1093/ejcts/ezs032

PMid:22328624

Fujino T, Kinugawa K, Nitta D, Imamura T, Maki H, Amiya E et al. Donor age is a predictor of early low output after heart transplantation. J Cardiol. 2016;67(5):477-82.

https://doi.org/10.1016/j.jjcc.2015.07.007

PMid:26271447

Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM et al. Marginal car-diac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(1_supplement):I-27-I-32.

https://doi.org/10.1161/CIRCULATIONAHA.105.000737

Luckraz H, Goddard M, Charman SC, Wallwork J, Parameshwar J, Large SR. Early mortality after cardiac transplantation: should we do better? J. Heart Lung Trans-plant. 2005;24(4):401-5.

https://doi.org/10.1016/j.healun.2004.02.013

PMid:15797739

Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC, Keck BM et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J. Heart Lung Transplant. 2005;24(8):945-55.

https://doi.org/10.1016/j.healun.2005.05.018

PMid:16102427

Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transplant International. 2008;21(2):113-25.

https://doi.org/10.1111/j.1432-2277.2007.00603.x

PMid:18062790

Blumer V, Marbach J, Veasey T, Kanwar M. Role of medical management of cardio-genic shock in the era of mechanical circulatory support. Curr Opin Cardiol. 2022;37(3):250-60.

https://doi.org/10.1097/HCO.0000000000000966

PMid:35612937

Romanowski B, Pharm D. Congenital heart defects, heart surgeries, low cardiac out-put syndrome. 2020.

Pollock KA, McMillan Z, Gert Diederick Pretorius V, Cronin B. Low cardiac output af-ter orthotopic heart transplant secondary to large inferior vena cava thrombus after prothrombin complex: a case report. A&A Practice.

2017;8(3):43-6.

Lim HS, Ranasinghe A, Chue C, Quinn D, Mukadam M, Mascaro J. Cardiac power output index and severe primary graft dysfunction after heart transplantation. J Car-diothorac Vasc Anesth. 2021;35(2):398-403.

https://doi.org/10.1053/j.jvca.2020.07.020

PMid:32747204

Jha AK, Hittalmani SK. Septic Shock in Low-Cardiac-Output Patients With Heart and Lung Transplantation: Diagnosis and Management Dilemma. J Cardiothorac Vasc Anesth. 2017;31(4):1389-96.

https://doi.org/10.1053/j.jvca.2016.11.003

PMid:28094175

Marasco SF, Vale M, Pellegrino V, Preovolos A, Leet A, Kras A et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann. Cardiothorac. Surg. 2010;90(5):1541-6.

https://doi.org/10.1016/j.athoracsur.2010.05.066

PMid:20971259

Singh TP, Profita EL, Rycus P, Thiagarajan R, Gauvreau K. Risk factors for severe pri-mary graft dysfunction in infants following heart transplant. Am Heart J. 2021;10(13):e021082.

https://doi.org/10.1161/JAHA.121.021082

PMid:34184543 PMCid:PMC8403271

McAree D, Yu S, Schumacher KR, Lowery R, McCormick AD, Thorsson T et al. Predic-tors and clinical significance of pericardial effusions after pediatric heart transplan-tation. Pediatr Transplant. 2022;26(1):e14153.

https://doi.org/10.1111/petr.14153

PMid:34585497

Menu E, Kabtani J, Roubin J, Ranque S, L'Ollivier C. Pericardial Effusion Due to Tri-chosporon japonicum: A Case Report and Review of the Literature. Pathogens. 2022;11(5):598.

https://doi.org/10.3390/pathogens11050598

PMid:35631119 PMCid:PMC9145057

Almenar L, Osa A, Martinez-Dolz L, Miró V, Quesada T, Cano O et al., editors. Echo-cardiographic evaluation of the evolutionary changes after heart transplantation. Transplant. Proc.; 2006: Elsevier.

https://doi.org/10.1016/j.transproceed.2006.08.033

PMid:17098007

Fröhlich GM, Keller P, Schmid F, Wolfrum M, Osranek M, Falk C et al. Haemodynam-ically irrelevant pericardial effusion is associated with increased mortality in pa-tients with chronic heart failure. Eur Heart J. 2013;34(19):1414-23.

https://doi.org/10.1093/eurheartj/eht006

PMid:23355650

Stämpfli SF, Özkartal T, Hagenbuch N, Bernhart S, Flammer AJ, Vecchiati A et al. Pericardial effusion unrelated to surgery is a predictor of mortality in heart trans-plant patients. Cardiol J. 2018;25(6):714-21.

Essandoh M. Atypical Presentation of a Large Pericardial Effusion after Heart Trans-plantation in a Patient with Dilated Cardiomyopathy. J Cardiothorac Vasc Anesth. 2018;32(4):e84.

https://doi.org/10.1053/j.jvca.2018.01.008

PMid:29429930

Urbanowicz T, Staburzyńska-Migaj E, Pawłowska M, Żabicki B, Michalak M, Filipiak M et al. EuroSCORE is a predictor of postoperative pericardial effusion following heart transplantation. Ann Transplant. 2015;20:193-7.

https://doi.org/10.12659/AOT.892582

PMid:25847682

Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M, Argulian E. Natriuretic peptides to differentiate constrictive pericarditis and restrictive cardiomyopathy: A systematic review and meta-analysis. Clin Cardiol. 2022;45(3):251-7.

https://doi.org/10.1002/clc.23772

PMid:34967020 PMCid:PMC8922532

Sohal S, Mathai SV, Lipat K, Kaur A, Visveswaran G, Cohen M et al. Multimodality Imaging of Constrictive Pericarditis: Pathophysiology and New Concepts. Curr Cardiol Rep. 2022:1-15.

https://doi.org/10.1007/s11886-022-01758-6

PMid:35917048 PMCid:PMC9344806

Ismail TF. Acute pericarditis: update on diagnosis and management. Clin Med (Northfield Il). 2020;20(1):48.

https://doi.org/10.7861/clinmed.cme.20.1.4

PMid:31941732 PMCid:PMC6964178

Welch TD. Constrictive pericarditis: diagnosis, management and clinical outcomes. Heart. 2018;104(9):725-31.

https://doi.org/10.1136/heartjnl-2017-311683

PMid:29175978

Tchana-Sato V, Ancion A, Ansart F, Defraigne JO. Constrictive pericarditis af-ter heart transplantation: a case report. Eur. Heart J. Case Rep. 2020.

https://doi.org/10.1093/ehjcr/ytaa240

PMid:32974473 PMCid:PMC7501930

Bansal R, Perez L, Razzouk A, Wang N, Bailey L. Pericardial constriction after cardiac transplantation. J. Heart Lung Transplant. 2010;29(3):371-7.

https://doi.org/10.1016/j.healun.2009.07.015

PMid:19804990

Aliabadi-Zuckermann AZ, Gökler J, Kaider A, Riebandt J, Moayedifar R, Osorio E et al. Donor heart selection and outcomes: An analysis of over 2,000 cases. J. Heart Lung Transplant. 2018;37(8):976-84.

https://doi.org/10.1016/j.healun.2018.04.014

PMid:29802081

Katz M, Freimark D, Raichlin E, Har-Zahav Y, Arad M, Kassif Y et al. Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation Registry. Clin Transplant. 2017;31(10):e13063.

https://doi.org/10.1111/ctr.13063

Almenar L, Garcı́a-Palomar C, Martı́nez-Dolz L, Chamorro C, Moro J, Zorio E et al., editors. Influence of induction therapy on rejection and survival in heart trans-plantation. Transplant. Proc.; 2005: Elsevier.

https://doi.org/10.1016/j.transproceed.2005.09.154

PMid:16386616

Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Hsich E et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report-2019; focus theme: donor and recipient size match. J. Heart Lung Transplant. 2019;38(10):1056-66.

https://doi.org/10.1016/j.healun.2019.08.004

PMid:31548031 PMCid:PMC6816343

Pérez-Carrillo L, Sánchez-Lázaro I, Triviño JC, Feijóo-Bandín S, Lago F, Gonzá-lez-Juanatey JR et al. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients. J. Heart Lung Transplant. 2022;41(2):137-47.

https://doi.org/10.1016/j.healun.2021.10.004

PMid:34895840

Billingham M, CARY NB, Hammond M, Kemnitz J, Marboe C, McCallister H. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. Heart Transplant. 1990;9(6):587-93.

Alexander RT, Steenbergen C. Cause of death and sudden cardiac death after heart transplantation: an autopsy study. Am J Clin Pathol. 2003;119(5):740-8.

https://doi.org/10.1309/713JVR58EF916DN5

Lee JM, Choi KH, Choi J-O, Shin D, Park Y, Kim J et al. Coronary microcircula-tory dysfunction and acute cellular rejection after heart transplantation. Circulation. 2021;144(18):1459-72.

https://doi.org/10.1161/CIRCULATIONAHA.121.056158

PMid:34474597

Ram E, Klempfner R, Peled A, Kassif Y, Sternik L, Lavee J et al. Weight gain post-heart transplantation is associated with an increased risk for allograft vascu-lopathy and rejection. Clin Transplant. 2021;35(3):e14187.

https://doi.org/10.1111/ctr.14187

PMid:33314309

Chin C, Naftel DC, Singh TP, Blume ED, Luikart H, Bernstein D et al. Risk fac-tors for recurrent rejection in pediatric heart transplantation: a multicenter experi-ence. J. Heart Lung Transplant. 2004;23(2):178-85.

https://doi.org/10.1016/S1053-2498(03)00059-7

PMid:14761765

Husain N, Watanabe K, Berhane H, Gupta A, Markl M, Rigsby CK et al. Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy. J Cardiovasc Magn Reson. 2021;23(1):1-13.

https://doi.org/10.1186/s12968-021-00803-7

PMid:34809650 PMCid:PMC8607604

Pérez-Carrillo L, Giménez-Escamilla I, Sánchez-Lázaro I, Triviño JC, Feijóo-Bandín S, Lago F et al. Alpha-cardiac actin serum expression levels detect acute cel-lular rejection in heart transplant patients. Transplantation. 2022:10.1097.

留言 (0)

沒有登入
gif